Mitchell Dann insider trades: Urologix (ULGX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mitchell reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 12, 2013 | ULGX | ↑ Buy | 20,000 | $0.30 | $6K | Direct | Jul 15, 2013 (3d) |
| Jun 29, 2012 | ULGX | ↑ Buy | 100,000 | $0.75 | $75K | By Trust | Jul 2, 2012 (3d) |
| May 27, 2010 | TSON | ↑ Buy | 12,500 | $2.95 | $37K | Direct | May 27, 2010 (0d) |
| Nov 4, 2009 | TSON | ↑ Buy | 12,500 | $4.00 | $50K | Direct | Nov 4, 2009 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mitchell Dann's insider trades
Mitchell Dann is a director at Urologix (ULGX). Since Nov 4, 2009, Mitchell has reported 4 open-market purchases worth $168K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (18 filings), option exercises (2 filings), gifts (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ULGX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.